CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 13 enrolled
Drug / intervention
Oliphenolia® bitter +2 moredietary
Likely dose
La Vialla Extra Virgin Olive Oil containing 5 mg hydroxytyrosolfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04876261
NCT04876261N/ACompleted

Bioavailability of Hydroxytyrosol From Two Olive Watery Extract Supplements and Their Effects on Lipid Peroxidation

Daacro·interventional·Posted May 6, 2021·Updated Jul 14, 2021

In Brief

A clinical study evaluating Oliphenolia® bitter, Oliphenolia®, and 1 other intervention for Biological Availability. Completed, enrolled 13 participants across 1 site.

Detailed Summary

The aim of this cross-over study is to assess the bioavailability of hydroxytyrosol in healthy males after the intake of two olive watery extract supplements and one olive oil. Blood and urine samples will be collected before and after intake of the investigational products. Sample will be analysed regarding the level of hydroxytyrosol and preventing lipid peroxidation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesGermany

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMay 6, 2021
Enrollment StartMay 10, 2021
Primary CompletionJul 2, 2021
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.2 years ago

Interventions

Oliphenolia® bitterdietary

* ingredients: concentrated watery extract of olives 94%, lemon juice 6% * 35 mg hydroxytyrosol, 0,24 mg Oleuropein

Oliphenolia®dietary

* ingredients: grape juice concentrate 70%, concentrated watery extract of olives 30% * 38 mg hydroxytyrosol, 0,28 mg Oleuropein

La Vialla Extra Virgin Olive Oil containing 5 mg hydroxytyrosoldietary

* extra virgin olive oil * 5 mg hydroxytyrosol